Genetic dissociation of opiate tolerance and physical dependence in δ-opioid receptor-1 and preproenkephalin knock-out mice

Journal of Neuroscience

Volumn 22, Issue 24, 2002, Pages 10906-10913

  Nitsche, Joshua F ^a   Schuller, Alwin G P ^a   King, Michael A ^b   Zengh, Min ^a   Pasternak, Gavril W ^b   Pintar, John E ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Dependence; Morphine; NMDA receptor; Opiate; Tolerance; opioid receptor, preproenkephalin; opioid receptor

Indexed keywords

MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OPIATE; PREPROENKEPHALIN; PROTEIN; PROTEIN DOR 1; PROTEIN PPENK; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG TOLERANCE; GENE EXPRESSION; GENE MUTATION; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INBRED STRAIN; KNOCKOUT MOUSE; MOLECULAR GENETICS; MOUSE; NOCICEPTION; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WITHDRAWAL SYNDROME;

EID: 0037115025     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-24-10906.2002     Document Type: Article

References (52)

1. Abbadie C, Pasternak GW (2001) Differential in vivo internalization of MOR-1 and MOR-1C by morphine. NeuroReport 12:3069-3072.
2. Abdelhamid EE, Sultana M, Portoghese PS, Takemori AE (1991) Selective blockage of δ opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258:299-303.
3. Aley KO, Levine JD (1997a) Dissociation of tolerance and dependence for opioid peripheral antinociception in rats. J Neurosci 17:3907-3912.
4. Aley KO, Levine JD (1997b) Different mechanisms mediate development and expression of tolerance and dependence for peripheral μ-opioid antinociception in rat. J Neurosci 17:8018-8023.
5. Arden JR, Segredo V, Wang Z, Lameh J, Sadee W (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J Neurochem 65:1636-1645.
6. Bernstein MA, Welch SP (1998) μ-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res Mol Brain Res 55:237-242.
7. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT (1999) Enhanced morphine analgesia in mice lacking β-arrestin 2. Science 286:2495-2498.
8. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG (2000) μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-723.
9. Corbett AD, Gillan MG, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE (1984) Selectivities of opioid peptide analogues as agonists and antagonists at the δ-receptor. Br J Pharmacol 83:271-279.
10. Elliott K, Minami N, Kolesnikov YA, Pasternak GW, Inturrisi CE (1994) The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the μ-opioid morphine but not to κ opioids. Pain 56:69-75.
11. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gaveriaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL (2000) Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25:195-200.
12. Gaveriaux-Ruff C, Filliol D, Simonin F, Matthes HW, Kieffer BL (2001) Immunosuppression by μ-opioid antagonist naltrindole: δ- and triple μ'2fδ'2fκ-opioid receptor knockout mice reveal a nonopioid activity. J Pharmacol Exp Ther 298:1193-1198.
13. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA (2000) Heterodimerization of μ and δ opioid receptors: A role in opiate synergy. J Neurosci 20:RC110(1-5).
14. Gonzalez P, Cabello P, Germany A, Norris B, Contreras E (1997) Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. Eur J Pharmacol 332:257-262.
15. Harrison LM, Kastin AJ, Zadina JE (1998) Opiate tolerance and dependence: Receptors, G-proteins, and antiopiates. Peptides 19:1603-1630.
16. He L, Fong J, von Zastrow M, Whistler JL (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108:271-282.
17. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ, von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
18. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, von Zastrow M (1998) μ-Opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53:377-384.
19. Kest B, Lee CE, McLemore GL, Inturrisi CE (1996) An antisense oligodeoxynucleotide to the δ opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Res Bull 39:185-188.
20. Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GW (1993) Blockade of tolerance to morphine but not to K opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 90:5162-5166.
21. Kolesnikov YA, Jain S, Wilson R, Pasternak GW (1998) Lack of morphine and enkephalin tolerance in 129/SvEv mice: Evidence for a NMDA receptor defect. J Pharmacol Exp Ther 284:455-459.
22. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentler M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283:401-404.
23. Lee NM, Leybin L, Chang JK, Loh HH (1980) Opiate and peptide interaction: Effect of enkephalins on morphine analgesia. Eur J Pharmacol 68:181-185.
24. Maldonado R, Negus S, Koob GF (1992) Precipitation of morphine withdrawal syndrome in rats by administration of μ-, 100 - and κ-selective opioid antagonists. Neuropharmacology 31:1231-1241.
25. Maldonado R, Blendy JA, Tzavara E, Gass P, Roques BP, Hanoune J, Schutz G (1996) Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273:657-659.
26. Manning BH, Mao J, Frenk H, Price DD, Mayer DJ (1996) Continuous co-administration of dextromethorphan or MK-801 with morphine: Attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 67:79-88.
27. Mao J (1999) NMDA and opioid receptors: Their interactions in antinociception, tolerance and neuroplasticity. Brain Res Brain Res Rev 30:289-304.
28. Mao J, Price DD, Mayer DJ (1994) Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C. J Neurosci 14:2301-2312.
29. Mastrogiacomo A, Evans CJ, Gundersen CB (1994) Antipeptide antibodies against a Torpedo cysteine-string protein. J Neurochem 62:873-880.
30. McLemore GL, Kest B, Inturrisi CE (1997) The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res 778:120-126.
31. Miyamoto Y, Portoghese PS, Takemori AE (1993) Involvement of δ2 opioid receptors in the development of morphine dependence in mice. J Pharmacol Exp Ther 264:1141-1145.
32. Nestler EJ (1997) Molecular mechanisms of opiate and cocaine addiction. Curr Opin Neurobiol 7:713-719.
33. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63.
34. Nestler EJ, Alreja M, Aghajanian GK (1994) Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus. Brain Res Bull 35:521-528.
35. Pasternak GW, Inturrisi C (1995) Pharmacological modulation of opioid tolerance. Exp Opin Invest Drugs 4:217-281.
36. Pasternak GW, Kolesnikov YA, Babey AM (1995) Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology 13:309-313.
37. Rady JJ, Holmes BB, Tseng LF, Fujimoto JM (2001) Inverse agonist action of Leu-enkephalin at δ2-opioid receptors mediates spinal antianalgesia. J Pharmacol Exp Ther 297:582-589.
38. Rezvani A, Hwang F, Song ZH, Lin ET, Way EL (1990) Supersensitivity to electrical stimulation for assessing physical dependence on opioids in isolated tissues. J Pharmacol Exp Ther 254:52-57.
39. Salmon AM, Damaj MI, Marubio LM, Epping-Jordan MP, Merlo-Pich E, Changeux JP (2001) Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in α CGRP-deficient mice. Nat Neurosci 4:357-358.
40. 35S]GTPγS autoradiography in rat brain. J Neurosci 16:2684-2692.
41. Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, Martin TJ (2000) Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 20:4555-4562.
42. Sternini C, Spann M, Anton B, Keith Jr DE, Bunnett NW, von Zastrow M, Evans C, Brecha NC (1996) Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc Natl Acad Sci USA 93:9241-9246.
43. Thorat SN, Barjavel MJ, Matwyshyn GA, Bhargava HN (1994) Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice. Brain Res 642:153-159.
44. Trujillo KA (2000) Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berl) 151:121-141.
45. Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87.
46. Trujillo KA, Akil H (1994) Inhibition of opiate tolerance by noncompetitive N-methyl-D-aspartate receptor antagonists. Brain Res 633:178-188.
47. Trujillo KA, Akil H (1995) Excitatory amino acids and drugs of abuse: A role for N-methyl-D-aspartate receptors in drug tolerance, sensitization, and physical dependence. Drug Alcohol Depend 38:139-154.
48. Way EL, Loh HH, Shen FH (1969) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 167:1-8.
49. Weber E, Evans CJ, Chang JK, Barchas JD (1982) Antibodies specific for α-N-acetyl-β-endorphins: Radioimmunoassays and detection of acetylated β-endorphins in pituitary extracts. J Neurochem 38:436-447.
50. Weber E, Esch FS, Bohlen P, Paterson S, Corbett AD, McKnight AT, Kosterlitz HW, Barchas JD, Evans CJ (1983) Metorphamide: Isolation, structure, and biologic activity of an amidated opioid octapeptide from bovine brain. Proc Natl Acad Sci USA 80:7362-7366.
51. Zheng M, Pintar JE (1995) Analysis of ontogeny of processing enzyme gene expression and regulation. In: Peptidases and Neuropeptide Processing, Methods in Neurosciences (Smith IA, ed), pp 45-64. London: Academic.
52. Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, Unterwald E, Pasternak GW, Pintar JE (1999) Retention of supraspinal δ-like analgesia and loss of morphine tolerance in δ opioid receptor knockout mice. Neuron 24:243-252.